A. Nurachman, “PHARMACOVIGILANCE AND OFF-GUIDELINE USE FOR GABAPENTIN IN FIBROMYALGIA: A REVIEW OF SAFETY PROFILES AND PRESCRIBING PATTERNS”, JRPPS, vol. 4, no. 1, pp. 31–42, Jun. 2025.